chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient was administered fluad vaccine and pneumovax 23 on tuesday 9/3/2019. patient called pharmacy wednesday 9/4/2019 to report that she had a reaction to "the pneumonia vaccine" that she received the day before. she stated that she had a local reaction at injection site and that over night she became weak and dizzy and experienced sweating. she took aleve and was starting to feel better. I advised her to report these side effects to her primary care doctor as well. i advised her to apply a cool compress to the injection site  as well as take either APAP or IBU for symptoms (said she has taken both of these products successfully in the past). I advised patient to seek medical attention if symptoms do not improve or worsen.
Patient admitted to hospital on 6/16/2021. Patient was experiencing chest pain with intermittent shortness of breath for two weeks prior to presenting to emergency department. Troponin on admission 0.98, increased to 1.35 on following day then decreased to 0.85.  ECHO was within normal limits. Patient discharged on 6/18/2021 and will have repeat troponin/ECHO in 4 weeks.  Patient received Pfizer Covid vaccine on 4/26 and 5/17/2021.
Lymphadenitis - (L) posterior neck. Raised erythematous rash (L) posterior neck and upper chest.
Pt. fainted walking out of the office. Then again as we tried to get her to a seat.
spoke with pt she had a pneumovax in her right deltoid in the office  Arm was very painful and was unable to use it on 6/4/19 Arm was limp per pt. She continues to have a mild headache sl nausea and chills. No fever. She says her arm is getting better using heat and ice as needed. Apap and ibuprofen as needed for discomfort . patent had declined an office visit.
On 12/23/2020 woke up with Fever 100.6 F, significant muscle aches, headache, diarrhea, and dizziness.
My left hand felt swollen and tingling,  I couldn't close the hand without significant pain, and I had trouble holding onto things.  It didn't look swollen, just felt that way.  If I bumped it a very sharp pain would blast the whole hand.
Patient provides no complaints but is evaluated of lethargy and depression and treated for Covid.  HPI  54 year old male with htn, diabetes, CVA, and depression presents with lethargy and is treated for Covid.
Patient was given TDAP vaccine per Nurse. Approximately 2-3 minutes later, patient became unresponsive for approximately 10 seconds, when he became cognitive of situation, he described symptoms of fatigue and visual disturbance. Pt became diaphoretic and ambulance was called to transfer to ER. State lasted approx. 4-5 min.
I awoke the morning after the vaccine injection and noticed I was suffering from a substantial hearing loss in both ears.  Additionally, my Tinnitus was very loud.  My hearing was very muffled, similar to having congestion in the inner ear, and was also very tinny.  I would estimate the loss at about 40 - 50%.  Over the next three weeks the symptoms have become intermittent but have not subsided in intensity.  Aside from some previously diagnosed high frequency hearing loss I have never experienced a blanket loss of hearing suddenly in both ears.  This all began less than 24 hours after the third vaccine injection.
Fatigue; This is a spontaneous report received from non-contactable reporter(s) (Pharmacist).  A 27-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 01Nov2023 as dose 1, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunisation; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: FATIGUE (non-serious) with onset 02Nov2023, outcome "recovered" (Nov2023). Therapeutic measures were not taken as a result of fatigue.  Additional information: No COVID prior vaccination. No COVID tested post vaccination.   The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Wrong shot given - was given DTaP/IPV. Should have given DTaP & HIB.
patient developed cough, runny nose, and body aches on 7/17/2021.  She tested positive for COVID on 7/19/2021.
Excessive abdominal gas with pain; This is a spontaneous report from a non-contactable nurse (patient).  A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number not reported, via an unspecified route of administration on Arm Left from 04Jan2021 14:45 to 04Jan2021 14:45 as single dose for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  On 04Jan2021 18:00, the patient experienced excessive abdominal gas with pain with outcome of recovering. No treatment was received for the event. Since the vaccination, has the patient has not been tested for COVID-19.  No follow-up attempts are possible; Information about batch/lot number cannot be obtained. No further information is expected.
Pt recv vax on 11/17/98; on 11/18/98 pt exp swollen Rt Arm
Pt vaccinated with DTP developed a fever with temp of 101.8. Pt hospitalized one day following event.
Patient visited Medical Clinic on 03/16/2021, attending provider, for symptoms of cramping stomach, big body shakes, night sweats, severe diarrhea, and pain in pubic area. Labs were collected but contaminated due to diarrhea. Advised to return following day, 03/17/2021, for labs, attending provider. Started to feel better around March 20th, still not great. Received second COVID shot on 04/06/2021. Sick from that day on. April 9th reported fever of 101, still having night sweats. April 14th visited Medical Clinic, attending provider. Blood work collected. White blood cells were 28.24. Augmentin was prescribed and patient was referred to a physician on 04/15/2021. Collected addition blood labs and urine sample. Elevated white blood cell count was 31.76. Doctor referred patient to specialist. Appt on April 26th.
suddenly at night I felt itchy hands, knees, neck, face, you could not believe it, you can't imagine; in the place of the shot is swollen; started feeling very bad, swollen, tired and I wasn't able to move my neck, everything was bad; face was swollen; neck became like red red red red, it was very hot; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (started feeling very bad, swollen, tired and I wasn't able to move my neck, everything was bad), SWELLING FACE (face was swollen), ERYTHEMA (neck became like red red red red, it was very hot), PRURITUS (suddenly at night I felt itchy hands, knees, neck, face, you could not believe it, you can't imagine) and VACCINATION SITE SWELLING (in the place of the shot is swollen) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (started feeling very bad, swollen, tired and I wasn't able to move my neck, everything was bad), SWELLING FACE (face was swollen), ERYTHEMA (neck became like red red red red, it was very hot) and VACCINATION SITE SWELLING (in the place of the shot is swollen). On 19-Mar-2021, the patient experienced PRURITUS (suddenly at night I felt itchy hands, knees, neck, face, you could not believe it, you can't imagine). On 19-Mar-2021, MUSCULOSKELETAL STIFFNESS (started feeling very bad, swollen, tired and I wasn't able to move my neck, everything was bad), SWELLING FACE (face was swollen), ERYTHEMA (neck became like red red red red, it was very hot) and VACCINATION SITE SWELLING (in the place of the shot is swollen) had resolved. At the time of the report, PRURITUS (suddenly at night I felt itchy hands, knees, neck, face, you could not believe it, you can't imagine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included applying rosewater topically for itching
Patient received pfizer booster left arm after administering patient was been observed began to feel dizzy, blurry and white vision, nausea, Ringing of right ear. Patient was lowered to the ground patient received crackers, water. Patient states this has happened before when getting blood drawn and denies eating or drinking anything prior to vaccination. Patient and guardian denied when offered emt services. Patient was sitting back up in chair with in 5 mins of vaccination. Patient and guardian states they will call HCP if needed for additional are.
Became very ill night of injection and continued to get worse with cough, chest pain and coughing up stuff. Bad cough still to this day.
NOSE DRIP; This spontaneous report received from a patient concerned multiple female patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subjects experienced nose drip. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of nose drip was not reported. This report was non-serious. This case, from the same reporter is linked to 20210411567.; Reporter's Comments: This report contains multiple patient
10 mins p/vax inject site became inflammed 5" x 5" & a white welt devel @ site of puncture; pt c/o warmth @ site & burning; pt took advil; 315PM pt c/o nausea & feeling warm; color pale; no rash; pt denied SOB; site less inflam;tx w/ DPH;
Patient received Janssen vaccine on 08/04/2021, developed rashes in the torso and back on 08/09/21 &08/10/21. Also, had an episode of nausea and fell unwitnessed on 08/05/2021. Patient reports she hit back and left shoulder and c/o lower back pain and pain is improving gradually. Denies any ambulation difficulties and or neural changes. Denies head hit.
got both shots,I have them again/suspected vaccination failure; got both shots, have them again; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 24-Jul-2022 Reporter's Comments: This case was received from consumer via interactive digital media The reporter stated that the patient  got both shots and he/she thought have them again. The follow-up would not possible as no contact details were available. Additional supportive information: The case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation was not given.
Headaches from 07/01/2003-07/05/2003.  Was bitten by a tick on 07/05/2003 and was not diagnosed with Lyme until 02/04.  Tests were inconclusive with Lymerix in the results.  Since I have the HLADR4 Gene I am still resistant to treatment for Lyme after 1 1/2 years of treatment.  I have neuropathic symptoms in my feet and face, and severe back pain (scoliosis, kyphosis, and face arthropathy aggrevated by Lyme) prior to vaccine.
This spontaneous report as received from a registered nurse refers to a female patient with currently 38 years old. The patient's current conditions includes; multiple sclerosis and drug allergy to MOTRIN. On an unspecified date in 2011, the patient was vaccinated with two doses of VARIVAX (Merck), (lot number and expiration date unknown), dose, route and anatomical location unspecified. Concomitant therapies included AMPYRA, GILENYA, glatiramer acetate, levofloxacin, MACROBID, ORTHO TRI-CYCLEN, oxybutynin and terconazole. On an unknown date (reported as recently), the patient had titers drawn which showed negative immunity. No treatment was given for the event. The outcome of the events was reported as not recovered/not resolved. Additional information has been requested.
Very large red knot on arm.  Showed up about 10 hours after vaccine. Sore and can?t life arm. Still here on 12/30 at 11:05pm.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 43 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "Known allergies: Sulfur" (unspecified if ongoing), notes: Known allergies: Sulfur. Concomitant medication(s) included: CARVEDILOL; HYDRALAZINE. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown"; COVID-19 (medically significant), outcome "unknown", described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19 with antiviral from 22Jun2022 to Jun2022 (Lot number=GA5120). The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Heat at site of injection; Itchiness at site of injection; Soreness at site of injection; Redness at site of injection; Raised area developed under site of injection; Raised rash 4 X 2 inches in diameter at site of injection; Soreness at site of injection; Redness at site of injection; Warm to touch at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Warm to touch at site of injection), INJECTION SITE WARMTH (Heat at site of injection), INJECTION SITE PRURITUS (Itchiness at site of injection), the first episode of INJECTION SITE PAIN (Soreness at site of injection) and the first episode of INJECTION SITE ERYTHEMA (Redness at site of injection) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.). Concomitant products included OLMESARTAN, ALPRAZOLAM (XANAX), VITAMIN D3 and PANTOPRAZOLE for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INJECTION SITE WARMTH (Warm to touch at site of injection), the first episode of INJECTION SITE PAIN (Soreness at site of injection) and the first episode of INJECTION SITE ERYTHEMA (Redness at site of injection). On 01-Mar-2021, the patient experienced INJECTION SITE WARMTH (Heat at site of injection), INJECTION SITE PRURITUS (Itchiness at site of injection), the second episode of INJECTION SITE PAIN (Soreness at site of injection), the second episode of INJECTION SITE ERYTHEMA (Redness at site of injection), INJECTION SITE SWELLING (Raised area developed under site of injection) and INJECTION SITE RASH (Raised rash 4 X 2 inches in diameter at site of injection). On 16-Feb-2021, INJECTION SITE WARMTH (Warm to touch at site of injection) had resolved. At the time of the report, INJECTION SITE WARMTH (Heat at site of injection), INJECTION SITE PRURITUS (Itchiness at site of injection), the last episode of INJECTION SITE PAIN (Soreness at site of injection), the last episode of INJECTION SITE ERYTHEMA (Redness at site of injection), INJECTION SITE SWELLING (Raised area developed under site of injection) and INJECTION SITE RASH (Raised rash 4 X 2 inches in diameter at site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the events included Benadryl.
Patient woke up with itches and rashes today (11FEB2020). No difficulty breathing.
localized reaction starting the following morning;   developed into cellulitis on left anterior thigh (11x11cm)
Patient is fully vaccinated.  COVID positive 12/29/2021 at ED visit. Chief complaint, cough and shortness of breath.sat is 95% Back Pain from cough. BP 157/72  | Pulse 84  | Temp 97.9 °F (36.6 °C) (Oral)  | Resp 22  | Ht 157.5 cm (5' 2")  | Wt 92.5 kg (204 lb)  | SpO2 95%  | BMI 37.31 kg/m²  CXR: Opacities are seen in the bilateral mid to lower lungs. stable vitals, she will come back if worse. Patient discharged from ED.
some congestion that just came on; her arm was really aching after the injection; she started coughing; voice was hoarse; light wheeze; soles of her feet were hurting; pressure in bilateral groin; aching all over; very tired; balance issues; This is a spontaneous report from a contactable nurse (patient).  A 62-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK9231) intramuscularly in left upper arm on 05Jan2021 at single dose for covid-19 immunisation. The patient got her Covid vaccine yesterday (05Jan2021) around 11 or 11:30 am in her left upper arm. She had bilateral breast cancer and had lymph nodes removed in each arm but more removed from her Right, so she got the vaccine in the left arm. She also had some skin cancers removed, one would not heal properly on her left arm and formed a blister, and her dermatologist popped it and put a band aid on it. The vaccine was given 3 inches above it. The patient's concomitant medications were not reported.  The patient experienced pressure in bilateral groin, aching all over, very tired and balance issues on 05Jan2021; light wheeze on 06Jan2021. Seriousness for these events was medically significant. The patient stated she had some congestion that just came on. She felt fine yesterday (05Jan2021) right after getting the vaccine, that at work she did notice that there was something different feeling in the left side of her groin. She was not in direct patient care. She noticed on her left side in the groin, something felt different, then yesterday evening (05Jan2021) after work she was really tired in the evening, aching all over last night, even the soles of her feet were hurting, woke up like her balance was off, she would walk one way and go another, states it is not like an orthostatic issue, that she knows what that feels like. She stated that in her inguinal area she could feel pressure, bilaterally. Her arm was really aching after the injection. Her breathing, heard a light wheezing, was clearing her voice, and then she started coughing, voice was hoarse.  The outcome of events pressure in bilateral groin, very tired and light wheeze was not recovered; of events aching all over and balance issues was recovering; of other events was unknown.; Sender's Comments: The reported events bilateral groin, aching all over, very tired, balance issues and light wheeze were possibly related to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), due to temporal relationship.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.
Patient received Gardasil 9, Menactra, and Adacel in clinic. Shortly after patient fainted and fell on the floor. Hit his face, was assessed by Dr. and no signs of injury or neurological changes present. Patient left clinic appearing well.
light fever; nausea; redness around the injection site that seems to be moving down her arm (the upper part of the; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (light fever), NAUSEA (nausea) and ERYTHEMA (redness around the injection site that seems to be moving down her arm (the upper part of the) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Latex allergy (Latex of the band aid).   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced PYREXIA (light fever), NAUSEA (nausea) and ERYTHEMA (redness around the injection site that seems to be moving down her arm (the upper part of the). On 18-Feb-2021, PYREXIA (light fever) and NAUSEA (nausea) had resolved. At the time of the report, ERYTHEMA (redness around the injection site that seems to be moving down her arm (the upper part of the) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Information has been received from a healthcare worker referring to unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored VAQTA (lot # L023936, expiration date 15-MAR-2017; lot # L045713, expiration date 14-JAN-2017; dose and route were unknown). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Subjective: 41-year-old female RN was received a flu shot on 11/02/2020. She reports she after the shot she felt dizzy. This has since resolved however she report the following day she developed swelling in the axilla the next day and this has since spread to the chest. She reports that she has pain in the axilla and about the injection site. She reports that the area of the injection site was erythematous afterwards for a day or two afterwards.  She tells me that the swelling is associated with tingling in the left hand.  She denies fevers or recent illness. She denies PMH or Med use other than Ibuprofen and Benadryl which she has been using for pain. She further tells me that she had a reaction to the H1N1 flu vaccine.  She denies allergies to medications otherwise.
Significant redness surrounding site of vaccine administration. (pt also experiencing persistent fever/chills/fatigue x 2 wks).